Dicot Pharma AB (STO:DICOT)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.6670
+0.0080 (1.21%)
At close: Jul 31, 2025
1.21%
Market Cap1.29B
Revenue (ttm)n/a
Net Income (ttm)-67.00M
Shares Out2.01B
EPS (ttm)-0.05
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,743,952
Average Volume9,335,245
Open0.6690
Previous Close0.6590
Day's Range0.6600 - 0.6870
52-Week Range0.1528 - 0.8990
Beta1.68
RSI55.93
Earnings DateAug 22, 2025

About Redfin

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It is developing LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 3
Stock Exchange Nasdaq Stockholm
Ticker Symbol DICOT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.